Research to help the most vulnerable
The RESIST speaker team: Prof. Dr. Thomas Schulz (in the middle) and the two co-speakers Prof. Dr. Gesine Hansen and Prof. Dr. Reinhold Förster
Some people become only mildly ill when they ’catch’ viral or bacterial infections, whereas others are affected much more severely. But what are the reasons for these differences? And how can the course of a disease be predicted and personalized treatments developed?
These questions are being addressed by the RESIST Cluster of Excellence team. This will enable them to help people with a weakened immune system, including newborn babies, the elderly, people with congenital immunodeficiency, those whose immune system is suppressed for therapeutic reasons, and implant users.
Our research programme is for the weakest. The current threat of the corona pandemic clearly shows how important the goals of our Cluster of Excellence RESIST are. We want to better understand the variable susceptibility of individuals to infections in order to protect vulnerable people as well as possible. In view of the dramatic situation, we in RESIST are also researching around SARS-CoV-2.
RESIST – News
Study on SARS-CoV-2: Cross-vaccination protects effectively
Combination of vaccines from AstraZeneca and Biontech/Pfizer protects particularly well - even with virus variants The Standing Committee on Vaccination (STIKO) supports a second vaccination with an mRNA vaccine such as the one from Biontech/Pfizer [...]
New in our RESIST team: Professor Depledge
Professor Daniel P. Depledge, PhD, Professor of Systems Biology of Viruses within the German Centre for Infection Research (DZIF) since June 2021 is a new member of RESIST. "The opportunity to expand my research interests and engage in translational [...]
The third dose
How long does the vaccination protection against SARS-CoV-2 last? Are ongoing vaccinations necessary? Prof. Schulz tells us what is currently known about it: Professor Schulz, how long is one protected against SARS-CoV-2 after the double vaccination [...]
Study on SARS-CoV-2: Cross-vaccination protects effectively
Combination of vaccines from AstraZeneca and Biontech/Pfizer protects particularly well - even with virus variants The Standing Committee on Vaccination (STIKO) supports a second vaccination with an mRNA vaccine such as the one from Biontech/Pfizer [...]
New in our RESIST team: Professor Depledge
Professor Daniel P. Depledge, PhD, Professor of Systems Biology of Viruses within the German Centre for Infection Research (DZIF) since June 2021 is a new member of RESIST. "The opportunity to expand my research interests and engage in translational [...]
Upcoming seminars
Every Thursday (except during school holidays) two RESIST scientists or top-class researchers from external institutions present their work at the RESIST seminar series. The seminars are taking place from 5 to 6 pm. Due to coronavirus pandemic, it is an online-seminar. If you want to take part ple [...]
